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The proliferative rate of hemopoietic progenitor cells, i.e. the
percentage of cells in the synthetic (8) phase of the cell cycle is a very
sensitive parameter for detecting the steady-state misbalance arising
in response to stimulatory or inhibitory molecules, or in
postmyeloablative repopulation of hemopoiesis. Thisparameter is also
predictive for the sensitivity of these cells to irradiation injury and
specific cytotoxic drugs. In spite of the fact that miniature inbred and
domestic pig breeds have been used as large animal models in
hemopoietic research and in experimental bone marrow
transplantation, data concerning the proliferative rate of porcine
progenitor cells are still lacking. The aim of this study was to examine
the steady-state proliferative rate of bone marrow and peripheral blood
erythroid progenitor cells of adult pigs. The percentage of cells in 8
phase of the cell cycle of both immature, BFU-E (Burst Forming
Unit-Erythroid) and mature, CFU-E (Colony Forming Unit-Erythroid)
erythroid progenitor cells was determined by the suicide technique
based on the proportion of these cells killed after in vitro treatment of
the cells with cytosine arabinoside (Ara-C). The results revealed
different relative numbers of immature and mature erythroid progenitor
cells in 8 phase of the cell cycle in the bone marrow, namely, 33.3%
for BFU-E and 55.1% for CFU-E. In peripheral blood the proliferative
rate of BFU-Eprogenitors was 26.3%. The data obtained show that the
proliferative rate of porcine erythroid progenitor cells is similar to the
values determined for other mammalian species.
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INTRODUCTION
The proliferative rate of a cell population may be represented as the number
of cells in the DNA-synthetic phase of the cell cycle in a defined interval of time
(Oehlert, 1973). According to modern concepts, maturing of stem and progenitor
cells is associated with the gradual elevation of the percentage of the population
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in the active phase of the cell cycle. While primitive categories of stem cells are
quiescent, up to 80% of cells of the maturest category of the erythroid lineage,
CFU-E, are in an active cell cycle. Most recent investigations indicate that primitive
stem cells are in a very slow cell cycle (Bradford et aI., 1997) ratherthan not cycling
at all. During the fetal and neonatal period the proliferative rate of hemopoetic
progenitor cells is high, but it declines during aging (Peschle et aI., 1981; Tejero
et aI., 1989). However, even in adults, stem and progenitor cells keep a high
reserve proliferative potential. For example, CFU-S (colony forming unit-spleen -
pluripotent progenitor cells) in steady-state have a proliferative rate of 10%, but
with increasing body demands for mature blood cells, it could reach 50% (Lajtha
et aI., 1969; Milenkovi6 et aI., 1993).
Cell cycle kinetics is regulated through a network of stimulatory and
inhibitory molecules, compensating increased or decreased body demands.
Moreover, various pathological processes, like neoplastic transformation of stem
or progenitor cells, can directly alter their proliferative activity. Numerous studies
have been related to murine and human stem and progenitor cells in S phase in
different conditions (Iscove, 1977; Hara & Ogawa, 1977; Gregory & Eaves, 1978;
Milenkovi6 & Pavlovi6-Kentera, 1979; Monette et aI., 1980; Kubota et aI., 1983;
Jovcic et aI., 1996, Ivanovi6, 1997). Reports on ovine (Barker, 1980), rat (Kimura
et aI., 1986; Basara et aI., 1988; Ivanovic et aI., 1995; Ivanovi6 et aI., 1995a), canine
(Abkowitz et aI., 1988) and feline (Linenberger et aI., 1991) progenitor cells in the
active phase of the cell cycle have been published, too.
In order to estimate the steady-state proliferative rate of bone marrow BFU-E
and CFU-E, and peripheral blood BFU-E progenitor cells of adult pigs, a colony
forming assay on methyl-cellulose, and the Ara-C suicide technique in vitro have
been used. Ara-C belongs to the group of S phase specific drugs and its primary
cytotoxic action results from incorporation into nucleic material and inadequate
ligation of fragments of newly synthesized DNA.
MATERIALS AND METHODS
Animals and cell suspensions
Blood and bone marrow samples were taken from 10 clinically normal
industrial breed pigs of both sexes, 4-6 months old. Blood samples (20 ml) were
collected from the jugular vein in sterile tubes with preservative-free sterile heparin
(40U/ml). The animals were stunned and slaughtered. Bone marrow was
harvested by direct surgical curettage from theoossis ishii (symphysis pelvis) (the
bodies passed through a warm water pool at 62 C), and the cells were suspended
in lscovezs Modification of Dulbeccozs Medium (IMDM, GibcoBRL, Life
Technologies, Paisley, Scotland) and constantly mixed for about one hour.
For all samples standard peripheral blood analysis was done. Mononuclear
cells (MNC) were obtained on a Ficoll-Hipac 1.077g/ml density gradient
(Lymphoprep, Nycomed, Oslo, Norway). Cell viability was determined before
plating using the trypan-blue exclusion test.
Determination of erythroid progenitor cells in S phase of the cell cycle
The Ara-C suicide assay was performed to determine the proportion of
progenitor c~lIs in the S phase of the cell cycle, (Shulman & Robinson, 1986).
Briefly, 5x10 cells were incubated for one hour with 40()..lg of Ara-C (Upjohn
Company, Kalamazoo, Michigan, USA) in IMDM, supplemented with 15% fetal
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calf serum (FCS, Serva Feinbiochernrca, New York, NY, USA) in 2 ml at 37°C in a
humidified atmosphere with 5% C02 in air (+ Ara-C sample). Cells incubated
under the same conditions without Ara-C were used as a control (- Ara-C sample).
At completion of the incubation period, the cells were washed in IMOM and
appropriately diluted suspensions were made to assay BFU-E and CFU-E
progenitors. The reduction in colony formation by the cells from samples treated
with Ara-C was proportional to the number of progenitors in DNA synthesis
(suicide), i.e. represented an indirect measure of the proportion of proliferating
progenitor cells.
No of colonies in the + Ara-C sample
Progenitor cells in S phase (%) = (1- --------- - ) x 100
No of colonies in the - Ara-C sample
Erythroid colony assays
The colony forming assay for BFU-E and CFU-E was performed according
to the original method of Iscove et aI., (1974)5Briefly, optimal growth conditions
for bone marrow BFU-E and CFU-E were 1x1 0 MNC plated in I ml of final mixture
containing 0.8% methylcellulose (ICN, Costa Mesa, IdsSA), 30% FCS, 2% bovine
serum albumin (BSA, Sigma, St Louis, MO, USA), 2x1 0 M (mercaptoethanol (ME,
Sigma, St Louis, MO, USA) and 61U of recombinant human erythropoietin (rhEpo,
Elanex Pharmaceuticals, Incs' Bothell, WA, USA) in IMOM. Cultivation of peripheralblood BFU-E required 1x1 0 MNC and the addition of 5% leukocyte conditioned
medium (LCM) in the final culture mixture. The culture mixtures were plated in
duplicate and incubated at 37°C in a humidified atmosphere with 5% C02 in air:
10 days for BFU-E and 4 days for CFU-E.
Statistical analysis
Data were subjected to descriptive statistical methods including the
arithmetic mean and standard error.
RESULTS
All determined peripheral blood parameters were in the physiological range
for pigs (data not shown). The viability of separated mononuclear cells before
plating was 90-95 % indicating that the procedure used was optimal for the
recovery of bone marrow and peripheral blood cells.
The proliferative rates of different categories of erythroid progenitor cells in
bone marrow and peripheral blood, determined on the basis of Ara-C suicide in
vitro, are presented in Table 1. The assessment of the proportion of progenitor
cells in S phase of the cell cycle revealed that in bone marrow the percentage of
BFU-E in active cell cycle was lower than the percentage of CFU-E. The cycling
status of peripheral blood BFU-E was slightly lower than the values found in bone
marrow, while CFU-E progenitors were not detected in pig blood.
The range of actual numbers of erythroid progenitor cells derived colonies
in bone marrow and peripheral blood and the range of their percentage in S phase
of the cell cycle are presented ir. Table 2 In bone marrow the number of CFU-E
derived colonies had a broader range than BFU-E, but higher variations in the
percentage of progenitor cells in S phase among the pigs were observed in BFU-E
progenitors. In peripheral blood, a broad range of both the number of BFU-E
derived colonies and their percentage in S phase was found.
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Table 1. The percentage of pig bone marrow and peripheral blood











After incubation of the cells with or without Ara-C, bone marrow BFU-E and CFU-
Ewere cultured in the presence of 6 IU rhEpo and peripheral blood BFU-E in the
presence of 61U rhEpo and 5% LCM. The percentage of progenitor cells in S
phase was determined on the basis of Ara-C suicide. The data are shown as
mean ±SEM
Table 2. The range of the actual number of erythroid progenitor cell derived
colonies and range of their percentage in S phase of the cell cycle
PROGENITORCELLS N° of colonies % in S phase
Bone marrow
BFU-E 41 - 86 19.8 - 53.6
CFU-E 336 -1016 50.0- 60.5
Peripheral blood
BFU-E 4-17 18.2 - 35.7
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For comparison of our results obtained in pigs with data published for other
mammalian species, values for the proliferative rate of the erythroid progenitor
cells are presented in Table 3.
Table 3. The percentage of bone marrow erythroid progenitor cells in S phase of the cell
cycle in man and some animal species.
Species % in S phase %inS cytotoxic References
BFU-E phase agent
CFU-E
Human 10 ±0.6 pBFU-E; 56 ±4.9 3H-TdR* Peschle et al., 1981
35 ± 1.5 iBFU-E
Dog 27 ±6 64 ±7 3H-TdR Abkowltz et aI., 1988
Cat 25 ±4 44 ±7 3H-TdR Linenberger et al., 1991
28 ±2 62 ±4 Abkowitz et al., 1988a
Rat 22 Ara-C Basara et al., 1988
19.4 68.2 3H-TdR Kimura et al., 1986
Mouse 30 ±8.1 76 ±2.7 3H-TdR Iscove, 1977
36 74 Hara & Ogavva, 1977
21.7 ±2.6 pBFU-E; 70.1 ±0,6 Gregory & Eaves, 1978
51.5 ±3 iBFU-E
76 ±8 HU-(invf.ro) Monette et al., 1980
22.8 ±4.9
Ara-C Jovcic et aI., 1996
*Tritiated thymidine """Hydroxyurea
The data are shown as mean ± SEM
DISCUSSION
The purpose of this study was to assess the percentage of pig bone marrow
and peripheral blood erythroid progenitor cells in S phase of the cell cycle in
steady-state, since data concerning the proliferative activity of porcine progenitor
cells are still lacking. The results obtained demonstrated different proportions of
immature and mature erythroid progenitor cells in S phase of the cell cycle in the
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bone marrow and peripheral blood and are in accordance with the majority of
numerous reports concerning the proliferative rate of erythroid progenitor cells in
other mammalian species, regardless of the different techniques used.
In mice and humans, primitive (pBFU-E) and intermediate BFU-E (iBFU-E)
could be distinguished, using the proportion of BFU-E progenitor cells in the active
cell cycle as one of the criteria. Murine primitive BFU-E have 20% of the cells in S
phase and intermediate 50% (Gregory & Eaves, 1978), while the corresponding
values for humans are 10% and 35%, respectively (Peschle et al., 1981). In our
experimental conditions 33% of the porcine bone marrow BFU-E population was
in S phase of the cell cycle. These progenitors were previously shown not to
respond to LCM as an exogenous source of growth factors other than Epo. On
the other hand their growth was absolutely Epo dependent as the number
drastically declined after postponing Epo addition for only 24 h (Kovacevic et ai,
1999). Taken together these data imply that bone marrow BFU-E in our
experimental conditions belong to the intermediate category of this progenitor cell
population.
The percentage of progenitor cells in active phase of the cell cycle has a
circadian rhythm, with up to 50% difference throughout each day as determined
by incorporation of BrdU (5-bromo-2-deoxyuridine) 0Nood et ai, 1998). These
daily variations are most likely related to the circadian rhythm ofthe concentrations
of hematopoietic stimulatory and inhibitory cytokines and hormones and could
be one of the explanations for individual differences in BFU-E proliferation rate in
our experiment.
One of the current questions raised on the basis of clinical trials of mobilized
peripheral blood stem cells is whether circulating progenitor cells may differ from
their bone marrow counterparts. It seems that peripheral blood BFU-E are
quiescent with respect to DNA synthesis (Ogawa et al., 1977; Peschle et al., 1981),
even in cytokine treated mice or humans. Since this quiescence was not due to
inhibitory substances in the blood (Roberts and Metcalf, 1995), it possibly reflects
a more primitive state. It is interesting to note that according to some investigators
even BFU-E from umbilical cord blood are noncycling cells (Schekhter-Levin et
al., 1984), while others report the presence of cycling BFU-E in fetal and neonatal
blood (Peschle et al., 1981). In contrast to these data, we have obtained a relatively
high proliferative rate for porcine peripheral blood BFU-E. This could be the result
of the inaccuracy of the test used, in respect to the small colony number obtained
in the colony forming assay and consequently the high percentage of reduction
in the colony number after the Ara-C treatment. On the other hand the high
proliferative rate could be a result of their different sensitivity to the cytotoxic agent
used. Kubota et al., (1983) reported that human BFU-E progenitors from
peripheral blood were insensitive to 3H thymidine, moderately sensitive to
hydroxyurea, and very sensitive to Ara-C. Our findings are similar to the
proliferative rate (36,6%) of a subpopulation of human peripheral blood BFU-E
separated on a discontinuous density gradient (Schekhter -Levin et al.,1985).
The observed high proliferative rate of porcine bone marrow CFU-E is
consistent with the values obtained in different species. Data showing that CFU-E
proliferative rate does not change, or changes only slightly in response to bleeding
(stimulation of erythropoiesis) or hypertransfusion (suppression of erythropoiesis)
(Iscove, 1977) point to a high proliferative rate as their intrinsic property.
Concerning the results obtained for the cycling status of porcine bone
marrow erythroid progenitors, as well as the strong Epa dependence for both
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BFU-E and CFU-E (Kovacevic et aI., 1999), it could be concluded that the
organization of the bone marrow compartment of pig erythroid progenitor cells is
comparable to humans and other animals investigated. As regards the
proliferative rate of peripheral blood BFU-E category of progenitor cells there are
conflicting reports and more investigations need to be performed to define these
values.
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OPREDELJENE MATICNE CELIJE ERITROPOEZE KOSTNE SRZII PERIFERNE KRVI SVINJA
U S FAZI CELlJSKOG CIKLUSA
MILICA KOVACEVIC, TATJANA BOZIC, V. PAVLOVIC, MARIJANA PETAKOV, DIANA BUGARSKI,
GORDANA JOVCIC i Z. IVANOVIC
SADRZAJ
Proliferativna aktivnost opredeljenih rnaticnih celija hematopoeze, odnosno
procenat ovih celija u S (sintetskoj) fazi celijskoq ciklusa je veoma osetljiv
parametar za odredivanje poremecaja fizioloskih vrednosti koje nastaju dejstvom
stimulatornih iii inhibitornih molekula, iii kod repopulacije hematopoeze posle
mijeloablacije. Ovaj parametar je takode vredan u ocenjivanju osetljivosti maticnih
celija na radijacione povrede iii odredene citotoksicne lekove. Uprkos cinjenici da
su kao eksperimentalni modeli u hematopoetskim istrazivanjima i u
eksperimentalnoj transplantaciji kostne srzi korisceni kako visoko-srodni sojevi
minijaturnih, tako i industrijske rase svinja, literaturni podaci 0 proliferativnoj
aktivnosti opredeljenih maticnih celija [os uvek nedostaju. Cilj ovog istrafivanja je
bio da se odrede proliferativne aktivnosti opredeljenih rnaticnih celija eritropoeze
iz kostne srzi i periferne krvi odraslih svinja u fizioloskirn uslovima. Procenat
opredeljenih rnaticnih celija za eritropoezu, BFU-E (Burst forming unit-erythroid) i
CFU-E (Colony forming unit-erythroid) u S fazi celijskog ciklusa je odredivan
tehnikom "suicida". Metoda se zasniva na in vitro "ubijanju" celija u S fazi celijskog
ciklusa citozin arabinozidom (Ara-C). Rezultati su pokazali da je procenat ranih i
zrelih opredeljenih rnaticnih celija za eritropoezu u S fazi celijskoq ciklusa razlicit,
i iznosio je 33,3% za BFU-E i 55,1% za CFU-E celije, U perifernoj krvi proliferativna
aktivnost BFU-E je iznosila 26,3%. Dobijeni rezultati pokazuju da je proliferativna
aktivnost opredeljenih rnaticnih celija eritropoeze kod svinja slicna vrednostima
dobijenim kod drugih vrsta sisara.
